Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Ovarian Neoplasms × Phlebotomy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Lung Neoplasms 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Lymphoma 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Brain Neoplasms 2 Adenocarcinoma 2 Urticaria 1 Tuberous Sclerosis 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Severe Combined Immunodeficiency 1 Salivary Gland Neoplasms 1 Renal Insufficiency, Chronic 1 Rectal Neoplasms 1 Pancreatitis, Chronic 1 Pancreatitis 1 Pancreatic Cyst 1 Ovarian Neoplasms 1 Non-alcoholic Fatty Liver Disease 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Nephritis 1 Neoplasm Metastasis 1 Multiple Sclerosis 1 Mucopolysaccharidosis I 1 Mastocytosis, Systemic 1 Mastocytosis 1

Interventions

Surveys and Questionnaires 19 Blood Specimen Collection 9 Hyperthermic Intraperitoneal Chemotherapy 7 niraparib 6 olaparib 5 Interviews as Topic 5 Cytoreduction Surgical Procedures 5 Carboplatin 5 Amplified Fragment Length Polymorphism Analysis 5 liposomal doxorubicin 4 Psychiatric Rehabilitation 4 Polymerase Chain Reaction 4 Immunohistochemistry 4 Geriatric Assessment 4 Data Collection 4 Bevacizumab 4 1-dodecylpyridoxal 4 Trabectedin 3 Therapeutics 3 Poly(ADP-ribose) Polymerase Inhibitors 3 Magnetic Resonance Spectroscopy 3 Gene Expression Profiling 3 Flow Cytometry 3 Cisplatin 3 CP protocol 3 Biopsy 3 Specimen Handling 2 Paclitaxel 2 Observation 2 Neoadjuvant Therapy 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02781272 2023-06-05

EMBER

Angle plc

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡